Literature DB >> 3510430

Detection and identification of activated oncogenes in spontaneously occurring benign and malignant hepatocellular tumors of the B6C3F1 mouse.

S H Reynolds, S J Stowers, R R Maronpot, M W Anderson, S A Aaronson.   

Abstract

Species- and strain-specific spontaneously occurring tumors have been observed in rodents maintained under normal laboratory conditions. Elucidation of the molecular mechanisms associated with the development of these spontaneous tumors may provide a better understanding of tumor development associated with exposure to chemical carcinogens. In view of the high frequencies of oncogene activation shown in rodent tumors induced by known chemical carcinogens, we have investigated oncogene activation in spontaneous tumors of the B6C3F1 mouse and Fischer 344/N rat by DNA transfection techniques. A marked difference in the presence of activated oncogenes in spontaneous rat tumors versus spontaneous mouse liver tumors was observed in this study. All rat tumors tested failed to yield activated oncogenes (0/29), whereas 30% (3/10) of mouse hepatocellular adenomas and 77% (10/13) of hepatocellular carcinomas scored positive by DNA transfection. These transforming genes were identified as an activated Ha-ras gene in all the adenoma transfectants and in 8 of the 10 carcinoma transfectants. The two remaining hepatocellular carcinomas contained transforming genes that appear not to be members of the known ras gene family. The B6C3F1 mouse liver system might provide a very sensitive assay not only for assessing the potential of a chemical to activate a cellular proto-oncogene, but also for detecting various classes of proto-oncogenes that are susceptible to mutational activation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3510430      PMCID: PMC322785          DOI: 10.1073/pnas.83.1.33

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells.

Authors:  M Wigler; S Silverstein; L S Lee; A Pellicer; Y c Cheng; R Axel
Journal:  Cell       Date:  1977-05       Impact factor: 41.582

3.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

4.  Mechanism of activation of a human oncogene.

Authors:  C J Tabin; S M Bradley; C I Bargmann; R A Weinberg; A G Papageorge; E M Scolnick; R Dhar; D R Lowy; E H Chang
Journal:  Nature       Date:  1982-11-11       Impact factor: 49.962

5.  A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene.

Authors:  E P Reddy; R K Reynolds; E Santos; M Barbacid
Journal:  Nature       Date:  1982-11-11       Impact factor: 49.962

6.  Oncogenes in human tumor cell lines: molecular cloning of a transforming gene from human bladder carcinoma cells.

Authors:  S Pulciani; E Santos; A V Lauver; L K Long; K C Robbins; M Barbacid
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

7.  Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas.

Authors:  A Balmain; M Ramsden; G T Bowden; J Smith
Journal:  Nature       Date:  1984 Feb 16-22       Impact factor: 49.962

8.  Monoclonal antibodies to the p21 products of the transforming gene of Harvey murine sarcoma virus and of the cellular ras gene family.

Authors:  M E Furth; L J Davis; B Fleurdelys; E M Scolnick
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

9.  Biochemical and immunological characterization of polyproteins coded for by the McDonough, Gardner-Arnstein, and Snyder-Theilen strains of feline sarcoma virus.

Authors:  M Barbacid; A V Lauver; S G Devare
Journal:  J Virol       Date:  1980-01       Impact factor: 5.103

10.  A novel ras-related gene family.

Authors:  P Madaule; R Axel
Journal:  Cell       Date:  1985-05       Impact factor: 41.582

View more
  43 in total

1.  Identification of an activated c-Ki-ras oncogene in rat liver tumors induced by aflatoxin B1.

Authors:  G McMahon; L Hanson; J J Lee; G N Wogan
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

2.  Mutational activation of the c-Ha-ras gene in liver tumors of different rodent strains: correlation with susceptibility to hepatocarcinogenesis.

Authors:  A Buchmann; R Bauer-Hofmann; J Mahr; N R Drinkwater; A Luz; M Schwarz
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

3.  Effects of endotoxin on expression of ras, p53 and bcl-2 oncoprotein in hepatocarcinogenesis induced by thioacetamide in rats.

Authors:  J M Yang; D W Han; Q C Liang; J L Zhao; S Y Hao; X H Ma; Y C Zhao
Journal:  World J Gastroenterol       Date:  1997-12-15       Impact factor: 5.742

Review 4.  Human cancer and cellular oncogenes.

Authors:  S Nishimura; T Sekiya
Journal:  Biochem J       Date:  1987-04-15       Impact factor: 3.857

5.  Conditional transformation of mouse liver epithelial cells. An in vitro model for analysis of genetic events in hepatocarcinogenesis.

Authors:  G H Lee; K Ogawa; N R Drinkwater
Journal:  Am J Pathol       Date:  1995-12       Impact factor: 4.307

6.  Biologic and molecular characterization of two newly isolated ras-containing murine leukemia viruses.

Authors:  T N Fredrickson; R R O'Neill; R A Rutledge; T S Theodore; M A Martin; S K Ruscetti; J B Austin; J W Hartley
Journal:  J Virol       Date:  1987-07       Impact factor: 5.103

Review 7.  Occurrence and relevance of chemically induced benign neoplasms in long-term carcinogenicity studies.

Authors:  J E Huff; S L Eustis; J K Haseman
Journal:  Cancer Metastasis Rev       Date:  1989-06       Impact factor: 9.264

8.  Parental bias of Ki-ras oncogenes detected in lung tumors from mouse hybrids.

Authors:  M You; Y Wang; G Stoner; L You; R Maronpot; S H Reynolds; M Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

Review 9.  Cancer genes: rare recombinants instead of activated oncogenes (a review).

Authors:  P H Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

10.  Long-term survival following treatment of hepatocellular carcinoma in Singapore: evaluation of Wellferon in the prophylaxis of high-risk pre-cancerous conditions.

Authors:  C J Oon
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.